Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Affordable Care Act
    • Consumer-Driven Health Care
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Drug Prices & Regulations
    • Health Economics & Costs
    • Health Insurance
    • Health Reform
    • Medical Tourism
    • Medicare
    • Single-Payer/Medicare-for-All
    • Telemedicine
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

What Happens When Seniors’ Share of Drug Costs Goes Down?

Posted on March 16, 2022March 21, 2022 by John C. Goodman

The change: Under the ACA, the coinsurance rate in the “donut hole” is being reduced from 100% in 2011 to 25% in 2022.

The results: No change in drug use. No change in total spending. But seniors did switch from generic to brand drugs more often.

Click her to view/download the Study

HT: Jason Shafrin

+

When is an FDA-Approved Drug Not a Drug?

Posted on March 14, 2022March 21, 2022 by Devon Herrick

In 2018 the Centers for Medicare and Medicaid Services (CMS) suddenly removed Auryxia (ferric citrate) from the Medicare Part D drug formulary and began to require prior authorization for the few indications it would reimburse. CMS gave little information about the reversal but apparently made the decision because it views ferric citrate at a mineral product, like dietary supplements such as Vitamin C. Dietary supplements are not covered by Medicare except in a few cases.

+

The Top 10 Health Care Scams of 2021

Posted on March 10, 2022March 21, 2022 by Devon Herrick

The Lown Institute recently released its Top 10 worse examples of profiteering and dysfunction in our health care system in 2021. Lown’s so-called Shkreli Awards were named after Martin Shkreli, the “pharma bro,” whose company became infamous for price gouging. After Turing Pharmaceuticals bought the 60-year old drug Daraprim, the price rose for $13.50 a pill to $750 a…

+
  • Previous
  • 1
  • …
  • 43
  • 44
  • 45
  • 46

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 9 other subscribers

Popular Topics

©2023 The Goodman Institute Health Blog | Website by Lexicom